Press release
Pain Management Devices Market to Witness Sustained Growth Through 2032 - Market Insights, Competitive Landscape, and Forecast | DelveInsight
Pain Management Devices Market
Technological advancements in neurostimulation devices, wearable pain relief solutions, radiofrequency ablation systems, and ultrasound-based therapies are transforming pain management by offering improved efficacy, safety, and patient convenience. Additionally, favorable reimbursement policies, growing awareness of alternative therapies, and increasing government initiatives around chronic pain management are further propelling market expansion.
DelveInsight's Pain Management Devices Market Insights report provides a comprehensive analysis of the evolving market landscape, highlighting key trends, growth drivers and challenges, regulatory and clinical developments, and payer dynamics. The report also profiles leading and emerging players, providing insights into competitive strategies, partnerships, and product innovation to support strategic business decisions.
With rising demand for personalized pain management, advancements in device technology, and increasing investment in non-pharmacological treatment options, the pain management devices market is expected to maintain a robust growth trajectory through 2032.
Explore the latest trends and growth drivers in the pain management devices market-download your sample report now https://www.delveinsight.com/report-store/pain-management-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Key Takeaways from the Pain Management Devices Market Report
• The pain management devices market was valued at USD 4.86 billion in 2023 and is projected to grow at a CAGR of 7.9%, reaching approximately USD 7.67 billion by 2032.
• As per DelveInsight estimates, North America is anticipated to dominate the global pain management devices market during the forecast period.
• Notable pain management devices companies such as Abbott Laboratories, Smith's Medical, B. Braun Melsungen AG, Baxter International Inc., Boston Scientific Corp., Colfax Corp., Medtronic plc., Nevro Corp., Abbott, Stryker, Omron Corporation, Stimwave LLC, Koninklijke Philips NV, Kimberly Clark Corporation, DJO Global LLC., Aleva neurotherapeutics SA, Motive Health, Inc., DyAnsys, Inc., NanoVibronix, Inc., Stratus Medical, LLC., and several others are currently operating in the pain management devices market.
• In March 2025, Aurora Spine Corporation announced that the FDA granted 510(k) clearance for its newest product, the AEROTM Facet Fusion System, further expanding its innovative spine and interventional pain management solutions.
• In September 2024, Nevro Corp., a leading global medical device company focused on delivering transformative solutions for chronic pain management, announced the U.S. Food and Drug Administration (FDA) approval and limited market release of the HFX iQTM system, featuring HFX AdaptivAITM. This advanced, responsive pain management platform enhances the HFX iQ spinal cord stimulation (SCS) system.
• In May 2023, Abbott announced that the FDA had approved its spinal cord stimulation (SCS) devices for treating chronic back pain in patients not eligible for back surgery, known as non-surgical back pain. This labeling expansion was supported by the DISTINCT study, which showed that Abbott's BurstDRTM SCS technology improved pain levels, daily activity performance, and emotional well-being in chronic back pain patients.
To read more about the latest highlights related to the pain management devices market, get a snapshot of the key highlights entailed in the global pain management devices market report here https://www.delveinsight.com/report-store/pain-management-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Pain Management Devices Overview
The pain management devices market focuses on medical technologies designed to alleviate acute and chronic pain across a wide range of conditions. These devices offer targeted, non-pharmacological solutions, helping reduce dependency on opioids and improving patient quality of life.
The market encompasses several device categories, including neurostimulation devices (spinal cord stimulators, peripheral nerve stimulators), transcutaneous electrical nerve stimulation (TENS) units, radiofrequency ablation devices, and wearable pain relief technologies. These innovations provide effective pain relief for conditions such as musculoskeletal pain, neuropathic pain, cancer-related pain, post-surgical pain, and more.
Pain Management Devices Market Insights
North America is expected to dominate the pain management devices market in 2023 and throughout the forecast period, driven by the growing prevalence of chronic pain and recent advancements in device approvals and launches. The rising burden of conditions like arthritis and high-impact chronic pain is significantly boosting demand across the region.
According to the CDC (2023), 20.9% of U.S. adults (51.6 million) reported chronic pain in 2021, while 6.9% (17.1 million) suffered from high-impact chronic pain. Additionally, in 2022, arthritis prevalence among U.S. adults was 18.9%, increasing sharply with age-further supporting the need for effective pain management solutions.
Pain management devices such as neurostimulation systems, joint braces, and neuromodulators offer non-invasive or minimally invasive approaches for managing pain associated with arthritis and other chronic conditions. Awareness initiatives like Pain Awareness Month, led by organizations such as the NIH, are also driving market growth by promoting early detection and effective pain management.
Recent product approvals are further accelerating the pain management devices market. In June 2021, NeuraLace's Axon Therapy® Peripheral Nerve Stimulation System received FDA clearance, while in December 2022, Abbott secured FDA approval for its EternaTM Spinal Cord Stimulation System, offering advanced pain relief with BurstDRTM stimulation.
Overall, these factors are expected to bolster the pain management devices market in North America throughout the forecast period.
To know more about why North America is leading the market growth in the pain management devices market, get a snapshot of the pain management devices market outlook here https://www.delveinsight.com/report-store/pain-management-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Pain Management Devices Market Dynamics
The pain management devices market is poised for strong growth, driven by the rising global burden of chronic conditions such as cancer and osteoarthritis. According to GLOBOCAN (2022), global cancer cases could rise from 20 million in 2022 to 32.6 million by 2045. Neuropathic cancer pain (NCP), often challenging to manage, is now seeing improved outcomes with advanced pain management devices.
Similarly, the Global Burden of Disease (2023) projects nearly 1 billion people will have osteoarthritis by 2050, with significant increases across major joints. The demand for effective, non-invasive pain management solutions is expected to surge, presenting key opportunities for innovation in the pain management devices market.
Product innovation continues to propel market growth. For example, in July 2023, Motive Health launched MotiveTM Knee-the first FDA-cleared, direct-to-consumer muscle stimulation device for knee pain, enabling broader access to advanced pain relief technologies.
Government-led awareness initiatives, such as the International Association for the Study of Pain's 2022 World Congress on Pain, are further driving market expansion by promoting early intervention and advanced treatment options.
However, alternatives like medications and physical therapy, along with risks of hypersensitivity or postoperative complications, may limit adoption and present challenges to the pain management devices market during the forecast period.
Get a sneak peek at the pain management devices market dynamics @ https://www.delveinsight.com/report-store/pain-management-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Coverage: Global
Study Period: 2022 to 2032
Pain Management Devices Market CAGR: ~7.90%
Key Pain Management Devices Companies: Abbott Laboratories, Smith's Medical, B. Braun Melsungen AG, Baxter International Inc., Boston Scientific Corp., Colfax Corp., Medtronic plc., Nevro Corp., Abbott, Stryker, Omron Corporation, Stimwave LLC, Koninklijke Philips NV, Kimberly Clark Corporation, DJO Global LLC., Aleva neurotherapeutics SA, Motive Health, Inc., DyAnsys, Inc., NanoVibronix, Inc., Stratus Medical, LLC., and others.
Pain Management Devices Market Segmentation
Market Segmentation By Type of Devices: (Neuromodulator & Neurostimulation Devices, Analgesic Infusion Pumps [Intrathecal Infusion Pumps and External Infusion Pumps], Ablation Devices [Radiofrequency Ablation Devices and Cryoablation Devices], and others)
Market Segmentation By Application: Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and others.
Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World.
Which MedTech key players in the pain management devices market are set to emerge as the trendsetter, explore @ https://www.delveinsight.com/report-store/pain-management-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Table of Contents
1. Pain Management Devices Market Report Introduction
2. Pain Management Devices Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Pain Management Devices Market Key Factors Analysis
6. Pain Management Devices Market Porter's Five Forces Analysis
7. Pain Management Devices Market Layout
8. Pain Management Devices Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us
Contact Us:
Jatin Vimal
jvimal@delveinsight.com
+14699457679
Healthcare Consulting
https://www.delveinsight.com/consulting-services
About DelveInsight
DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.
Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pain Management Devices Market to Witness Sustained Growth Through 2032 - Market Insights, Competitive Landscape, and Forecast | DelveInsight here
News-ID: 4057969 • Views: …
More Releases from DelveInsight
Lung Adenocarcinoma Clinical Trials Analysis 2025: Targeted Therapies, Immunothe …
DelveInsight's "Lung Adenocarcinoma - Clinical Trials Analysis, 2025" describes a dynamic and fast-moving development landscape focusing on two complementary goals: (1) inhibit tumor growth and progression through targeted and immune-based therapies, and (2) improve patient survival, quality of life, and functional outcomes. Current programs include EGFR, ALK, KRAS, and MET inhibitors, immune checkpoint inhibitors (PD-1/PD-L1, CTLA-4), and emerging bispecific antibodies and combination regimens designed to overcome resistance and enhance efficacy.
Late-stage…
Neurofibromatosis Type 1 Clinical Trials Analysis 2025: Targeted RAS-Pathway and …
The Neurofibromatosis Type 1 (NF1) clinical trial landscape in 2025 focuses on two main goals: controlling plexiform and cutaneous neurofibromas and preventing malignant peripheral nerve sheath tumors (MPNST) while improving quality of life. Current programs include RAS-MAPK pathway inhibitors, next-generation MEK inhibitors, mTOR modulators, immuno-oncology agents for MPNST, and early gene-directed therapies.
Late-stage trials primarily test oral RAS pathway inhibitors for pediatric plexiform neurofibromas, with attention to safety, functional improvement, and…
Neisseria Meningitidis Meningitis Clinical Trials Analysis 2025: Multivalent Vac …
DelveInsight's "Neisseria Meningitidis Meningitis - Clinical Trials Analysis, 2025" outlines a rapidly evolving landscape aimed at two primary goals: (1) provide broad serogroup coverage through next-generation multivalent and protein-based vaccines, and (2) improve long-term immunity and reduce disease incidence in adolescents, young adults, and high-risk populations. Ongoing programs include conjugate vaccines, adjuvanted formulations, and combination vaccines targeting meningococcal and other pediatric pathogens to optimize immunization schedules.
Late-stage and pivotal trials focus…
Essential Tremor Clinical Trials Analysis 2025: Novel Pharmacologics, Neuromodul …
DelveInsight's "Essential Tremor - Clinical Trials Analysis, 2025" highlights a dynamic development landscape focused on two complementary goals: (1) reduce tremor severity and improve motor control, and (2) enhance patient quality of life and daily functioning. Ongoing programs include small-molecule pharmacologics targeting GABAergic and calcium channel pathways, focused ultrasound neuromodulation, deep brain stimulation (DBS) refinements, and emerging gene therapy candidates aimed at long-term tremor suppression.
Late-stage and registration-enabling trials assess efficacy,…
More Releases for Pain
Enhanced Pain Relief Solutions at Advanced Pain Care
Image: https://www.globalnewslines.com/uploads/2025/03/3f3b6259bfdec02e5dcb7b9d0c838855.jpg
Advanced Pain Care is helping people who suffer from chronic pain with sophisticated, evidence-based treatments. The clinic is particularly focused on non-surgical care that improves the quality of life. With a team of highly qualified pain experts, they work with patients who have back pain, joint pain, and nerve pain.
Personalized Treatment for Every Pain Disorder
Advanced Pain Care offers treatments depending on the cause of pain. Anyone experiencing arthritis, migraine,…
Pain Finisher | Advanced Pain Relief Device
Pain Finisher is an instant pain relief device that is effective on all pains including back pain and knee pain. It is based on the TENS theory of pain management which is easy to use and safe.
By using Pain Finisher, a modern drug-free and non-invasive pain-relieving treatment method, one can get rid of the common pain creams, gels, and risky treatment methods.
So, have a pain-free life with easy-to-use pain relief…
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
Visceral Pain Market Analysis 2024: Addressing Pain Management Challenges
The Business Research Company has released its latest global market reports, covering insights for 2024 and offering projections up to 2033.
The Business Research Company presents an extensive market research report on the Visceral Pain Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments.
Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities,…
Global Post-Operative Pain Management Market: Pain Relief Goes Worldwide
Introduction:
The Global Post-Operative Pain Management Market is growing at a rapid pace. This market involves the management of pain after surgical procedures. The market has witnessed significant growth in recent years, owing to the increasing number of surgeries and the rising prevalence of chronic diseases. Pain management is an essential aspect of healthcare, as uncontrolled pain can lead to prolonged hospital stays, delayed recovery, and poor patient outcomes.
In this article,…
Post-Operative Pain Management Market By Type, By Application(Cancer Pain, Arthr …
Global Post-Operative Pain Management Market- Description
Post-operative pain management is predominantly referred to as the use of a wide array of therapies or drugs to reduce muscle and tissue spasm in patients who have recently undergone a surgical procedure. It is evident that all type of surgeries, be it major or minor cause postoperative pain in patients which in turn increases their hospital stays while burdening them with psychological and physical…
